Baseline measurement in osteoporosis
- bone mineral density assessment may be performed at the commencement of treatment for osteoporosis and then subsequently after more than 18 months on treatment (1)
- quantitation of urinary deoxypyridinoline/creatinine ratio to quantify bone turnover, initially, then whilst on treatment
Reference:
- (1) ARC.Hands On 2007;11:1-6.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.